Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $6.0400 (-2.82%) ($6.0400 - $6.0400) on Tue. Aug. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6% (three month average) | RSI | 46 | Latest Price | $6.0400(-2.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL advances 1.7% a day on average for past five trading days. | Weekly Trend | AUTL advances 3.4% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(54%) ARKG(49%) ARKK(49%) IWO(48%) IBUY(47%) | Factors Impacting AUTL price | AUTL will decline at least -3% in a week (0% probabilities). VIXM(-30%) VXX(-28%) SHY(-18%) TLT(-16%) XLU(-13%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3% (StdDev 6%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.02(0.33%) | 10 Day Moving Average | $5.78(4.5%) | 20 Day Moving Average | $5.81(3.96%) | To recent high | -23.9% | To recent low | 13.6% | Market Cap | $316m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |